Institute. Mesothelin/CD3e T ri-specific T -cell Activating Construct HPN536. NCI T hesaurus. Code C162935. recombinant antibody derivative composed of a tri-specific T -cell activating construct (T riT AC) directed against the human tumor-associated antigen (T AA) mesothelin (MSLN) and the epsilon domain of CD3 antigen (CD3e) found on T -lymphocytes which are both linked to either side of an anti-albumin single domain antibody, with potential immunostimulating and antineoplastic activities. Upon administration of the MSLN/CD3e T riT AC HPN536, the anti-MSLN single antibody domain targets and binds MSLN on tumor cells and the anti-CD3e single-chain variable fragment (scFv) targets and binds to CD3e on cytotoxic T -lymphocytes (CT Ls), thereby bringing MSLN-expressing tumor cells and CT Ls together, which results in the CT L-mediated cell death of MSLN-expressing tumor cells. T he albumin-binding domain targets and binds to serum albumin, thereby extending the serum half-life of HPN536. MSLN is overexpressed on the surface of certain tumor cell types. Overexpression of MSLN is often associated with poor prognosis.
